Altay Aliyev

Spesialisasi: Clinical oncologist
15 tahun pengalaman
Berbahasa:
Azerbaijani, English, Turkish
Konsultasi online: tersedia
Tempat kerja: Azerbaijão, Bacu, Liv Bona Dea Hospital Baku
Dr. Altay Aliyev Internal Diseases and Medical Oncology

Jelajahi paket bersama Dr. Altay Aliyev

Pilih Prosedur

Hipertermik İntraperitoneal Kemoterapi (Hyperthermic intraperitoneal chemotherapy)

$7,400

per paket

Paket mencakup rangkaian layanan medis standar dari klinik serta manfaat tambahan seperti akomodasi, transfer, dll.

Konsultasi online dengan Altay Aliyev

Mudah dan praktis

100% aman dan rahasia

Harga berdasarkan permintaan

Ulasan pasien

4.7

Skor sangat baik

16 ulasan pasien terverifikasi

1 bintang

2 bintang

3 bintang

4 bintang

5 bintang

100%

Rincian penilaian

Dokter

4.6/5

staf

4.7/5

Fasilitas

4.7/5

Bantuan bahasa

4.7/5

Dukungan

4.9/5

Kepercayaan Anda adalah prioritas utama kami

Kami menghargai kepercayaan Anda di atas segalanya, jadi klinik tidak bisa membayar untuk mengubah atau menghapus ulasan.

Pelajari lebih lanjut tentang ulasan.

Elizaveta Gnidash • Rinoplasti

Israel

24 Jan 2025

Ulasan terverifikasi.

I am very happy that I came to this clinic and to the people who are doing a great job

Layanan dokter

Bagaimana pelayanan kami?

1 dari 3

Informasi tentang dokter ini lengkap dan jelas.

Sangat tidak setuju

Sangat setuju

Kualifikasi

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr 18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery. • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations